Position in MRNA
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$915,782
+$259,650 QoQ
Shares Held
13,077
+1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#311
of 772 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $15,880,894 across 17 Biotechnology names. MRNA ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,438 | $6,178,327 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,651 | $1,653,004 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,155 | $1,250,779 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
13,677 | $1,070,498 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
13,077 | $915,782 | |
| 6 | CBUS |
Cibus, Inc.
|
576,043 | $789,178 | |
| 7 | INCY |
Incyte Corp
|
6,876 | $779,463 | |
| 8 | IMMX |
Immix Biopharma, Inc.
|
70,682 | $728,731 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $915,782 | 13,077 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $656,132 | 12,916 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $305,929 | 10,374 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $317,657 | 12,298 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $398,399 | 14,440 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $230,797 | 8,141 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $376,673 | 9,059 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $406,794 | 6,087 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,280,956 | 10,787 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,055,370 | 9,904 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $873,171 | 8,780 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $591,645 | 5,728 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $931,662 | 7,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,454,095 | 9,468 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $2,124,365 | 11,827 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $1,366,970 | 11,560 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,554,208 | 10,880 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,938,958 | 11,256 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,006,361 | 11,837 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,634,099 | 12,041 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,785,217 | 11,853 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,533,424 | 11,710 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,241,730 | 11,886 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $703,538 | 9,944 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $338,579 | 5,273 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||